Sarah Ackroyd

Assistant Professor

University of Chicago

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sarah Ackroyd is an Assistant Professor at the University of Chicago, USA. Her research primarily focuses on gynecologic oncology, with recent publications addressing areas such as the cellular dynamics of the human fallopian tube, disparities in surgical care for uterine cancer, and the survivorship needs of cervical cancer patients. Additionally, she explores the molecular characteristics of gynecologic cancers and the impact of telemedicine on patient care during the COVID-19 pandemic.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Ernst Lengyel

University of Chicago

UNITED STATES

View details

Nita K. Lee

University of Chicago Medicine

UNITED STATES

View details

Olga Fajardo

University of Wisconsin-Madison

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sarah Ackroyd

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

A cell atlas of the human fallopian tube throughout the menstrual cycle and menopause

Geographic and racial disparities in the quality of surgical care among patients with nonmetastatic uterine cancer

The burden of cervical cancer survivorship: Understanding morbidity and survivorship needs through hospital admissions

Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma

A molecular atlas of the human postmenopausal fallopian tube and ovary from single-cell RNA and ATAC sequencing

Lessons learned: Telemedicine patterns and clinical application in patients with gynecologic cancers during COVID-19

Surviving and thriving: What do survivors of gynecologic cancer want?

Pembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: A Markov analysis

Minimally invasive hysterectomy for endometriosis: Surgical outcomes based on surgeon specialty

Surgical outcomes of hysterectomy for endometriosis: Benefits of a minimally invasive approach

Collaborators (3)

Ernst Lengyel

Nita K. Lee

Olga Fajardo

Make your next move.